| 1 |
31340850 | Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma. | 2019 Jul 24 |
1 |
| 2 |
26964870 | Mouse models for ROS1-fusion-positive lung cancers and their application to the analysis of multikinase inhibitor efficiency. | 2016 May |
1 |
| 3 |
24419060 | The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice. | 2014 Feb |
4 |
| 4 |
25026277 | The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model. | 2014 Jul 30 |
1 |